Analyzing the Landscape: Cell-Based vs Antibody-Based Anti-BCMA Therapies - BCMA Targeted Therapies

Skip to content

24680 - BCMA Targeted Therapies (1)-1

Returning in December, 2023

REGISTER INTEREST

Home
About
- About Event
- Content Library
Program
- 2022 Event Guide
- 2022 Speakers
Partnership
- 2022 Partners
- Partnership Opportunities
Register Interest
Contact Us

Home
About
- About Event
- Content Library
Program
- 2022 Event Guide
- 2022 Speakers
Partnership
- 2022 Partners
- Partnership Opportunities
Register Interest
Contact Us

24680 - BCMA Targeted Therapies (1)-1

Analyzing the Landscape: Cell-Based vs Antibody-Based Anti-BCMA Therapies

Time: 8:56 am
day: Day One

Analyzing the Landscape: Cell-Based vs Antibody-Based Anti-BCMA Therapies');return false;" target="_blank">

Analyzing the Landscape: Cell-Based vs Antibody-Based Anti-BCMA Therapies');return false;" target="_blank">

OUR CONTACT DETAILS

T: (+1) 617 455 4188
E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

Hilton Boston Logan Airport

One Hotel Dr,
Boston, MA 02128
United States

SEARCH

Search

ORGANISED BY

Terms & Conditions

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.